What is the recommended dosage and treatment regimen for colchicine (Colchicine) in acute gout attacks?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Colchicine Dosing for Acute Gout Attacks

For acute gout attacks, colchicine should be administered as a loading dose of 1.2 mg followed by 0.6 mg one hour later, then continued at 0.6 mg once or twice daily until the acute attack completely resolves. 1, 2, 3

Recommended Treatment Regimen

Initial Dosing

  • First dose: 1.2 mg (two 0.6 mg tablets) at the first sign of gout flare
  • Second dose: 0.6 mg (one tablet) one hour later
  • Maximum dose: 1.8 mg over a one-hour period 3

Continuation Therapy

  • After the initial loading doses, continue with 0.6 mg once or twice daily (12 hours after the initial doses) until the gout attack resolves 2, 1
  • Most acute attacks resolve within 3-10 days with appropriate treatment 1

Timing Considerations

  • Colchicine is most effective when started within 36 hours of symptom onset 2, 1
  • Initiate treatment as soon as possible after symptom onset for maximum effectiveness 1

Dose Adjustments

For Patients Already on Prophylactic Colchicine

  • If a patient is already taking colchicine for prophylaxis and experiences a gout flare, they may take 1.2 mg at the first sign of flare followed by 0.6 mg one hour later
  • Wait 12 hours and then resume the prophylactic dose 3

For Renal Impairment

  • Dose reduction is required in moderate to severe chronic kidney disease 2, 1
  • Consult FDA-approved labeling for specific adjustments based on renal function 1

For Drug Interactions

  • Reduce or avoid colchicine when used with moderate to high potency inhibitors of Cytochrome P450 3A4 or P-glycoprotein 2, 1
  • Major interactions include clarithromycin, erythromycin, cyclosporine, and disulfiram 2

Important Considerations and Cautions

  • The low-dose regimen (1.8 mg total over 1 hour) has been shown to be as effective as higher doses while causing fewer adverse effects 4, 5
  • High-dose colchicine regimens can cause severe toxicity and are not recommended 1
  • Colchicine is not an analgesic medication and should not be used to treat pain from other causes 3
  • The safety and efficacy of repeat treatment for gout flares has not been evaluated 3

Alternative Treatments

If colchicine is contraindicated or not tolerated, consider:

  • NSAIDs at full anti-inflammatory doses until the attack resolves 2, 1
  • Oral corticosteroids (prednisone or prednisolone) at 0.5 mg/kg per day for 5-10 days 2, 1
  • Intra-articular corticosteroid injections for involvement of 1-2 large joints 2

Common Pitfalls to Avoid

  • Using outdated high-dose colchicine regimens, which increase risk of toxicity without improving efficacy 5
  • Failing to start treatment promptly (within 36 hours of symptom onset) 1
  • Not adjusting doses for renal impairment or drug interactions 2, 1
  • Continuing treatment beyond resolution of the acute attack 2
  • Overlooking the narrow therapeutic-toxicity window of colchicine 5

This low-dose colchicine regimen has been shown to be effective while minimizing gastrointestinal and other adverse effects, representing a significant improvement over older high-dose protocols 4, 5.

References

Guideline

Acute Gout Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Colchicine for the treatment of gout.

Expert opinion on pharmacotherapy, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.